Specialized Ophthalmology in Seoul · Dedicated International Patient Concierge
MOHW Registered · Foreign Patient Care
en-US
Medical Guide
LASIK in South Korea vs the US: Technology and Access
LASIK in South Korea vs the United States, compared on technology and access: what each regulator approves, how you reach surgery, what sets the date.
Schedule a ConsultationGetting LASIK in South Korea vs the United States: Cost, Technology, and Wait Times Compared
Medically reviewed by Dr. Kim Byoung Jin, Board-certified ophthalmologist (Korean Ophthalmological Society)
Comparing LASIK in South Korea with LASIK in the United States is usually framed as a question about money, and that framing hides the two things that actually differ. The lasers themselves are made by a small number of international manufacturers and appear in operating rooms on both sides of the Pacific; what differs is the regulatory machinery each country runs around them, and the path a person walks to get from "I am thinking about this" to a date in a surgical schedule. This article compares those two — technology and access — and treats the financial side structurally rather than numerically, because no figure here would be yours.
That last point deserves stating plainly at the outset. This article contains no prices, no ranges and no comparison of amounts. Vision correction surgery carries a fee that follows the plan drawn up for your individual eyes, Jamsil Samsung Eye Clinic issues a written quotation, and the amounts should be confirmed with the clinic directly rather than inferred from anything published generally.
What a device regulator decides — and what it has no authority over
The most useful thing an American reader can know about this comparison is how narrow the FDA's remit actually is. The agency states its own authority in unusually direct terms: it regulates the sale of medical devices in the United States and monitors the safety of regulated devices once they are marketed, which means a company wishing to sell a laser must first present evidence that it is reasonably safe and effective for a particular use.
Then comes the list of things the FDA says it cannot do. It does not regulate a doctor's practice, and does not tell physicians how to run their business or what to say to patients. It does not set what a doctor may charge for the surgery. It does not require that the manufacturer's patient information booklet reach the person being operated on. It does not recommend individual doctors, clinics or eye centers — the agency states that it neither maintains nor has access to any list of doctors performing the procedure. And it does not rate the devices it regulates.
Read that list carefully and the shape of the American system appears. Federal oversight stops at the machine. Everything downstream — who operates it, on which patients, after what examination, with what follow-up, at what fee — is governed by state medical licensing, professional standards and the individual practice. The regulator's approval of a laser tells you that a device cleared a defined evidentiary bar. It tells you nothing about the surgeon standing behind it.
How an approved-device list actually reads
The FDA publishes lists of approved lasers — one for LASIK, one for PRK and other refractive procedures — and what those entries contain is more interesting than the fact of approval. Each entry carries the specific treatment range for that laser, the manufacturer's contact details, the patient labeling and instructions for use, and any changes made to the device since it was approved.
The treatment range is the part patients rarely hear about and should. An approval is not a general license to treat any eye; it is an approval to treat within a stated band of refractive error. A prescription sitting outside that band is a different conversation, which is one of several reasons a clinic's answer to "can you treat my eyes" depends on measurements rather than enthusiasm.
The FDA also notes that these lists exclude cleared laser keratomes — the instruments used to make a flap — which is a reminder that a single procedure can involve more than one regulated device, each reaching the market by its own pathway.
South Korea runs an equivalent function through its Ministry of Food and Drug Safety, the national authority responsible for medical device regulation, which maintains its own English-language information for international readers. The practical consequence for a patient is simple: a device in use in a Seoul operating room sits under Korean device authorization, and a device in use in Ohio sits under American authorization. The manufacturers largely overlap. The paperwork does not, and neither does the regulator you would contact.
Why the same laser is not the same procedure
Suppose both clinics you are comparing run identical hardware. You have learned less than you think.
A refractive laser is programmed, not simply switched on. The treatment is planned from the measurements taken beforehand and adjusted by the surgeon's own correction factors, built up from how that surgeon's previous patients healed. The same machine in two hands produces two slightly different procedures, which is why the FDA's advice to patients concentrates on finding the right doctor rather than the right device, and why its own material on risks and on choosing a surgeon sits alongside its device lists rather than beneath them.
The examination matters at least as much. A laser can only act on a plan, and the plan is only as good as the corneal mapping, the pupil measurement, the refraction and the ocular health assessment that produced it. The National Eye Institute's patient material on refractive surgery makes the general point that these procedures are not suitable for everyone and that a thorough eye examination determines whether a person is a candidate.
So the comparison that is worth running between two countries is not a hardware inventory. It is: who examines me, what do they measure, who operates, and who sees me afterwards.
The technology in use at a Korean clinic, named plainly
Jamsil Samsung Eye Clinic's published equipment list for vision correction is a Triple A MEL 90 excimer laser and a Ziemer FEMTO LDV Z8 femtosecond laser, with an AVEDRO XTRA system used for corneal cross-linking where the cornea is to be strengthened. Its cataract and lens surgery runs on an ALCON INFINITI phacoemulsification system, and its presbyopia lens work includes a Clareon PanOptix trifocal implant.
The procedures those platforms support are Clear Smile LASIK, Z8 Premium LASIK, High Premium LASEK, Corneal Strengthening LASEK and the EVO AQUA ICL, with a 1-DAY vision correction pathway available for qualifying candidates. The clinic's stated reason for carrying that breadth is fit rather than novelty: having several approaches available means treatment can be selected according to the individual eye, with high myopia and thin corneas named among the conditions the range exists to cover.
The clinic is a registered medical institution for attracting foreign patients, certified by Korea's Ministry of Health and Welfare, and four board-certified ophthalmologists practice at the Songpa-gu premises.
Access in the United States: the search is yours to run
Here is where the FDA's list of limitations becomes a practical matter. Because the agency keeps no roster of surgeons and issues no ratings, an American patient assembles the shortlist themselves — from a referral by an optometrist or ophthalmologist, from a professional society's listing, from word of mouth, from advertising. The screening examination that follows is both a clinical gate and, in most practices, the first real appointment.
Several features of that pathway are worth naming:
- No gatekeeper is formally required. Refractive surgery sits outside covered care, so the referral machinery that governs much of American medicine does not apply in the usual way.
- The examination precedes everything. Candidacy is established by measurement, and the FDA's own list of findings that rule a person out — a cornea that is too thin, unstable refraction, an irregular corneal shape, certain eye diseases and systemic conditions — cannot be assessed in advance of it.
- Scheduling is practice-specific. How soon a consultation and then a surgical date become available depends on the individual practice's volume, not on a national queue.
- Follow-up is local, which is the quiet advantage. The surgeon who operates is a drive away for the reviews that follow.
Access in South Korea: a clinic-based outpatient model
The Korean pathway differs mainly in its directness and in the fact that it has to be arranged from abroad. Vision correction is delivered in specialist outpatient clinics that patients approach directly, and the first contact for an international patient is typically a written enquiry rather than a referral.
Jamsil Samsung Eye Clinic takes written questions and appointment requests through its online enquiry channel, offers telephone and online consultation, and has a dedicated English-speaking international coordinator, Kim Do-hee. The clinic states that it operates with no language limitations across its patient services and that translated documents are available. Consulting hours begin at 09:30 Korea Standard Time from Monday through Thursday and close at 19:00; Friday runs late as an evening clinic until 20:00; Saturday mornings open at 09:00 and continue without a lunch break until 13:00. Sundays and public holidays are closed. Two of those slots are usable by a working traveler without surrendering a weekday.
The comprehensive examination that decides candidacy is described as taking approximately two hours, and the clinic offers a 1-DAY evaluation-to-procedure schedule for candidates who qualify for it. Whether an individual eye qualifies is a finding, not a booking preference.
Wait times: what actually creates one
The phrase "wait times" suggests a queue, and for elective refractive surgery that is rarely the binding constraint in either country. Three other things usually set the calendar.
The first is the examination gate. Nothing can be scheduled until candidacy is established, and the examination cannot be compressed because some of its measurements take time to obtain properly.
The second is contact lens discontinuation, which is the lead time most people underestimate. Lenses reshape the cornea, so measurements taken too soon describe a cornea that is not the one the surgeon will treat. Two sets of instructions exist and they differ. Jamsil Samsung Eye Clinic asks for soft lenses to be stopped one week before diagnostic testing, hard or toric lenses two weeks, and orthokeratology lenses three weeks; its pre-surgery care page states one month for orthokeratology. The FDA's guidance is longer: two weeks for soft lenses, at least three weeks for toric soft or rigid gas permeable lenses, and at least four weeks for hard lenses. Where the two differ, the conservative interval is the one to plan around — and this period starts before the appointment, not after it.
The third is the stabilization requirement. A refraction that is still moving is not a basis for a permanent correction, and the clinic asks for vision that has been stable for approximately six months. For someone whose prescription changed recently, that is the real waiting period, and it exists identically in both countries.
For a patient traveling from the United States, a fourth constraint joins them: flights, lodging and the review appointments that have to happen in person. Those are planned around the clinical schedule rather than the other way around, and they are worth settling with the clinic in writing before anything is booked.
The structural side of what a total is built from
Both systems treat this surgery as care the patient pays for. In Korea, vision correction surgery is classified as non-covered general care, which means it sits outside the national health insurance benefit structure and is priced by the institution providing it. In the United States, refractive surgery is likewise not part of standard medical benefits, and the amount is set by the individual practice. Neither country has a published national tariff for it, and the FDA states explicitly that setting what a doctor charges is outside its authority.
What follows from that for a patient is procedural rather than numerical. The amount you will be asked for is produced by a plan drawn up for your eyes after examination, which is why a figure quoted before any measurement is a guess rather than a quotation. Jamsil Samsung Eye Clinic issues a written quotation once the plan is settled, and the amounts should be confirmed with the clinic rather than assumed from anything published generally.
Follow-up: the asymmetry that outlives the operation
The genuine disadvantage of the Korean route is not technological. It is that the surgeon who knows your eyes best will, at some point, be on the other side of an ocean.
The Centers for Disease Control and Prevention's guidance for travelers seeking care abroad stresses exactly this: planning for continuity of care, arranging how records will travel, and identifying who will provide follow-up after returning home are part of preparing for treatment overseas rather than afterthoughts. The CDC also advises obtaining copies of medical records and understanding what aftercare the treating facility provides.
Three practical moves follow. Settle before you travel who will see you at home and in what circumstances. Leave Seoul carrying your operative record and the details of the device and parameters used. And establish directly with the clinic how it handles questions from patients who have returned home — the international coordinator is the channel for that, and it is worth testing before surgery rather than after.
Questions that actually separate two clinics
If you want to compare a Korean clinic and an American practice on technology and access rather than on marketing, these are the questions that produce comparable answers:
- Which laser platforms would be used for my procedure, and what refractive range is each one authorized to treat?
- Which specific measurements will the preoperative examination include, and how long does it take?
- Who performs the surgery, and does that same person conduct the examination beforehand and the reviews afterwards?
- What is the required contact lens discontinuation period before my measurements, counted from today?
- Which in-person reviews must happen before I travel home, and who conducts them?
- How do I reach the clinic with a question once I am back in the United States, and in what language?
- What will the written quotation cover, and what is handled separately?
A practice that answers these in plain terms is telling you something about how it works. A practice that answers only the first is telling you something too.
What Jamsil Samsung Eye Clinic looks like on these terms
Jamsil Samsung Eye Clinic sits on the seventh floor of the Seokyeong Building on Olympic-ro in Songpa-gu, Seoul, and its team is four board-certified ophthalmologists working across vision correction, cataract and presbyopia surgery, retina and glaucoma care, orthokeratology and the dry eye and tear duct clinic. Its published strengths for international patients are breadth of procedure choice and the fact that the operating surgeon handles the examinations and the reviews personally rather than delegating them, which is the part of a care pathway that distance makes hardest to replicate. Background on the practice and its service lines is set out on the clinic's main site and in its about us section.
Nothing in this comparison can settle what your own eyes need, because that is produced by measurement. Written questions, requests for the examination and anything you want recorded before you commit to travel go through the clinic's enquiry and appointment page, where correspondence is handled in English and the quotation for your plan is issued in writing.
The Bottom Line
- The FDA states that it regulates the sale of lasers but has no authority over a doctor's practice, what a doctor charges, or any rating or listing of surgeons — so an approval describes a device, not a provider.
- The FDA's approved-device lists carry each laser's authorized treatment range, its patient labeling and its post-approval changes; Korea's Ministry of Food and Drug Safety performs the equivalent national function.
- The same hardware does not produce the same procedure: planning, correction factors and the quality of the preoperative examination sit between the machine and the result.
- Access differs in shape rather than in speed — the American route is a self-assembled search with local follow-up, the Korean route a direct clinic booking with English coordination and evening and Saturday hours.
- What usually sets the calendar is not a queue but the examination gate, the contact lens discontinuation period, and the requirement for a stable refraction.
Frequently Asked Questions
Is the laser technology used in South Korea different from what is used in the United States?
The manufacturers are largely the same international companies, and devices are authorized nationally rather than globally — by the FDA in the United States and by the Ministry of Food and Drug Safety in Korea. Jamsil Samsung Eye Clinic names a Triple A MEL 90 excimer laser and a Ziemer FEMTO LDV Z8 femtosecond laser among its vision correction platforms.
Does FDA approval of a laser mean the clinic using it has been approved?
No, and the FDA says so itself. It states that it does not regulate a doctor's practice, makes no recommendations about individual doctors or clinics, and neither maintains nor has access to a list of practitioners performing the surgery. Approval attaches to the device and its authorized treatment range.
How do I find out whether my prescription can be treated at all?
Through examination. The FDA lists an insufficiently thick cornea, an irregular or unstable corneal shape, unstable refraction and certain eye and systemic conditions among the findings that rule a person out, and each approved laser carries its own authorized treatment range. The clinic determines final eligibility through a comprehensive examination lasting approximately two hours.
How long before my measurements do I need to stop wearing contact lenses?
Two sets of instructions exist and the difference is useful to know. The clinic asks for one week without soft lenses, two weeks without hard or toric lenses and three weeks without orthokeratology lenses before diagnostic testing, with one month for orthokeratology stated in its pre-surgery care guidance. The FDA advises two weeks, at least three weeks and at least four weeks respectively.
Why can nobody give me a price before I am examined?
Because the fee follows the surgical plan, and the plan follows the measurements. Jamsil Samsung Eye Clinic issues a written quotation once the plan for your eyes is settled, and the amounts should be confirmed with the clinic directly. The FDA notes that what a doctor charges for the procedure is outside its authority entirely.
Is refractive surgery covered by insurance in either country?
It is treated as patient-funded care in both. In Korea, vision correction surgery is classified as non-covered general care and is priced by the institution providing it. In the United States it likewise falls outside standard medical benefits. Confirm your own position with your insurer before planning anything around it.
Who looks after me once I am back in the United States?
That should be arranged before you leave. The CDC's guidance for people seeking care abroad emphasizes planning continuity of care, obtaining copies of medical records and identifying who will provide follow-up at home. The clinic's international coordinator handles correspondence in English, and establishing that channel before surgery is more useful than discovering it afterwards.
This article is for general informational purposes and does not constitute individualized medical advice. It is not a self-diagnosis tool. Surgical candidacy, technique, and expected outcomes can only be determined through a consultation with a qualified ophthalmologist.
More Articles
Continue reading our clinical ophthalmology guides.
LASIK Cost Korea vs US: How Each System Sets Prices
LASIK cost in Korea vs the US differs because each system treats vision correction as elective. How pricing is structured, and how to request a real quote.
Learn More
Dr. Kim Byoung Jin: Ophthalmologist in Seoul, Korea
Dr. Kim Byoung Jin is a board-certified ophthalmologist and representative director at Jamsil Samsung Eye Clinic, Seoul. His training and focus, explained.
Learn More
Book an Online Consultation: Korea Eye Clinic Guide
Book an online consultation with a Korea eye clinic: the channels this Seoul practice documents, the time-zone arithmetic, and what to assemble up front.
Learn More